CRSR
Corsair Gaming, Inc.
CRSR's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over CRSR overall, supported by stronger valuation and stronger fundamentals.
CRSR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRSR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CRSR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $12.28 | — |
| Cheap | 18x | $7.00 | -43% |
| Fair | 30x | $11.35 | -7.5% |
| Current | 32x | $12.28 | — |
| Expensive | 99x | $37.59 | +206% |
Historical ranges are pointers, not guarantees.
CRSR's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over CRSR in the historical PE scenario, which offers more potential upside but is not a forecast.
CRSR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CRSR, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
CRSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.79 | +107% |
| Q3 2026 | $0.38 | +$0.72 |
| Q2 2026 | $0.31 | +$1.12 |
| Q1 2026 | $0.09 | +$1.02 |
| Q4 2025 | -$0.12 | +$0.83 |
| Q3 2025 | -$0.34 | +$0.62 |
| Q2 2025 | -$0.81 | -$0.38 |
| Q1 2025 | -$0.93 | -$0.79 |
| Q4 2024 | -$0.95 | -$0.92 |
CRSR has returned to profit: it earned $0.38 per share over the past year, after losing money the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CRSR on earnings, with more consistent year-over-year improvement.
CRSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367M | +6.1% |
| Q2 2026 | $314.3M | -1.8% |
| Q1 2026 | $354.5M | -4.1% |
| Q4 2025 | $436.9M | +5.6% |
| Q3 2025 | $345.8M | +14% |
| Q2 2025 | $320.1M | +23% |
| Q1 2025 | $369.8M | +9.6% |
| Q4 2024 | $413.6M | -0.9% |
CRSR's revenue is recovering but still below its 2020 peak: $367M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +1.2 points |
| Q2 2026 | 2.4% | +7.7 points |
| Q1 2026 | 3.9% | +4.5 points |
| Q4 2025 | 6.2% | +4.7 points |
| Q3 2025 | -1.6% | +5.3 points |
| Q2 2025 | -5.3% | +4.2 points |
| Q1 2025 | -0.6% | +2.4 points |
| Q4 2024 | 1.4% | -1.5 points |
CRSR's operating margin was −0.5% last quarter, up 1.2 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CRSR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CRSR on profitability, with a higher operating margin.
CRSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | +$24.6M |
| Q2 2026 | $72.1M | +162% |
| Q1 2026 | $26.1M | +66% |
| Q4 2025 | $32.9M | -39% |
| Q3 2025 | -$41.3M | -290% |
| Q2 2025 | $27.5M | +$48.5M |
| Q1 2025 | $15.7M | +$44.5M |
| Q4 2024 | $54.1M | -1.9% |
CRSR usually generates cash, though not every quarter: the latest was −$17M, but it generated $114M over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CRSR on cash flow, with more consistent year-over-year improvement.
CRSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -487K shares |
| 1 year | +2.3% | +2.4M shares |
| 3 years | +5.7% | +5.8M shares |
| 5 years | +8.7% | +8.7M shares |
| Available history | +18% | +16.9M shares |
CRSR has 109M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $962,000 |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over CRSR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
CRSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -1.3x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.5x | Healthy |
| Q2 2024 | 11.2x | High |
| Q1 2024 | 1.4x | Healthy |
| Q4 2023 | 0.4x | Very low |
| Q3 2023 | 1.3x | Healthy |
CRSR has more cash than debt.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CRSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 40.1 | Neutral |
CRSR's weekly RSI is 55 (neutral) and its Stochastic is 40 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CRSR PE vs Technology Sector
| Metric | CRSR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 16% above |
| PE % | 55 | 38 | 17 pts above |
CRSR is trading at 32x earnings, a 16% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over CRSR on valuation relative to its sector.
CRSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 5.8% below |
| 20 week MA | $12.2 | 1.1% above |
| 50 week MA | $8.83 | 39% above |
| 100 week MA | $8.67 | 42% above |
| 200 week MA | $10.8 | 14% above |
CRSR has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
CRSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $36.4 | +111% |
| 2021 | $36.4 | $22.4 | -38% |
| 2022 | $22.4 | $13.7 | -39% |
| 2023 | $13.7 | $14.1 | +2.6% |
| 2024 | $14.1 | $6.55 | -54% |
| 2025 | $6.55 | $6.10 | -6.9% |
| 2026 YTD | $6.10 | $12.3 | +101% |
CRSR's yearly returns have swung widely, from +111% in 2020 to −54% in 2024. It's up 101% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CRSR on returns for 2026, with the stronger performance.